EP1976503 - GASTRIC RETENTIVE GABAPENTIN DOSAGE FORMS AND METHODS FOR USING SAME [Right-click to bookmark this link] | Status | The application has been refused Status updated on 15.03.2013 Database last updated on 02.11.2024 | Most recent event Tooltip | 15.03.2013 | Refusal of application | published on 17.04.2013 [2013/16] | Applicant(s) | For all designated states Depomed, Inc. 1360 O'Brien Drive Menlo Park, CA 94025 / US | [2008/41] | Inventor(s) | 01 /
BERNER, Bret 424 Lee Avenue Half Moon Bay, California 94019 / US | 02 /
HOU, Sui Yuen Eddie 380 Shad Court Foster City, California 94404 / US | 03 /
GANA, Theophilus J. 200 Lawson Road SE Leesburg, Virginia 20175 / US | 04 /
CRAMER, Marilou S. 1736 Kansas Street Redwood City, California 94061 / US | [2008/41] | Representative(s) | Brasnett, Adrian Hugh, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [N/P] |
Former [2008/41] | Brasnett, Adrian Hugh, et al Mewburn Ellis LLP York House 23 Kingsway London WC2B 6HP / GB | Application number, filing date | 06848292.6 | 29.12.2006 | [2008/41] | WO2006US49511 | Priority number, date | US20050322448 | 29.12.2005 Original published format: US 322448 | US20060852534P | 17.10.2006 Original published format: US 852534 P | [2008/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2007079195 | Date: | 12.07.2007 | Language: | EN | [2007/28] | Type: | A2 Application without search report | No.: | EP1976503 | Date: | 08.10.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.07.2007 takes the place of the publication of the European patent application. | [2008/41] | Search report(s) | International search report - published on: | EP | 30.08.2007 | Classification | IPC: | A61K31/195, A61K9/00, A61P25/00 | [2008/41] | CPC: |
A61K9/0065 (EP);
A61K31/135 (EP);
A61K31/195 (EP);
A61K31/197 (EP);
A61K31/4166 (EP);
A61K31/53 (EP);
A61K31/55 (EP);
A61K45/06 (EP);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/06 (EP);
A61P25/08 (EP);
A61P25/24 (EP);
A61P29/00 (EP);
A61P29/02 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/41] | Title | German: | MAGENRETENTIVE GABAPENTIN-DOSIERFORMEN UND ANWENDUNGSVERFAHREN | [2008/41] | English: | GASTRIC RETENTIVE GABAPENTIN DOSAGE FORMS AND METHODS FOR USING SAME | [2008/41] | French: | FORMES POSOLOGIQUES DE GABAPENTINE A RETENTION GASTRIQUE ET LEURS PROCEDES D'UTILISATION | [2008/41] | Entry into regional phase | 17.07.2008 | National basic fee paid | 17.07.2008 | Designation fee(s) paid | 17.07.2008 | Examination fee paid | Examination procedure | 08.07.2008 | Amendment by applicant (claims and/or description) | 17.07.2008 | Examination requested [2008/41] | 06.11.2008 | Despatch of a communication from the examining division (Time limit: M06) | 24.06.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 01.09.2009 | Reply to a communication from the examining division | 09.02.2012 | Cancellation of oral proceeding that was planned for 07.03.2012 | 07.03.2012 | Date of oral proceedings (cancelled) | 05.11.2012 | Cancellation of oral proceeding that was planned for 08.11.2012 | 08.11.2012 | Date of oral proceedings (cancelled) | 29.11.2012 | Despatch of communication that the application is refused, reason: substantive examination [2013/16] | 09.12.2012 | Application refused, date of legal effect [2013/16] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 06.11.2008 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 01.09.2009 | Request for further processing filed | 01.09.2009 | Full payment received (date of receipt of payment) | Fees paid | Renewal fee | 24.12.2008 | Renewal fee patent year 03 | 28.12.2009 | Renewal fee patent year 04 | 27.12.2010 | Renewal fee patent year 05 | 27.12.2011 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.12.2012 | 07   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [DXY]US2003100611 (BERNER BRET [US], et al) [DXY] 1-71 * examples 1-4; claims 20-29,36,78-87,94 * * paragraphs [0006] , [0012] , [0025] , [0026] , [0032] , [0040] - [0042] *; | [XY]US2005064036 (BERNER BRET [US], et al) [XY] 1-71 * claims 1,2,21,24 * * paragraphs [0005] , [0013] , [0026] , [0033] , [0038] , [0041] , [0043] * * examples 1-8 *; | [XY]US2003104053 (GUSLER GLORIA [US], et al) [XY] 1-71 * claims 1,16,20 * * paragraphs [0004] , [0017] * * example 2 *; | [Y]US2003031711 (FARA JOHN W [US], et al) [Y] 1-71 * claims 1-4,20 *; | [DY]US6310098 (GUTTUSO JR THOMAS J [US]) [DY] 1-71 * claims 1,3,7 *; | [PX]US2006159743 (BERNER BRET [US], et al) [PX] 1-71 * claims 1-44 * | [Y] - BENNETT M I ET AL, "GABAPENTIN IN THE TREATMENT OF NEUROPATHIC PAIN", PALLIATIVE MEDICINE, LONDON, GB, (200401), vol. 18, no. 1, ISSN 0269-2163, pages 5 - 11, XP009047587 [Y] 1-71 * page 7, column 2, paragraph 3 - page 8, column 2, paragraph 3 * DOI: http://dx.doi.org/10.1191/0269216304pm845ra | [Y] - RICHTER R W ET AL, "PREGABALIN OR MORPHINE AND GABAPENTIN FOR NEUROPATHIC PAIN", EXPERT OPINION ON PHARMACOTHERAPY, ASHLEY, LONDON,, GB, (200511), vol. 6, no. 14, ISSN 1465-6566, pages 2535 - 2539, XP009075939 [Y] 1-71 * whole document * DOI: http://dx.doi.org/10.1517/14656566.6.14.2535 | [Y] - WESCHE D ET AL, "A pharmacokinetic comparison of pregabalin and gabapentin", JOURNAL OF PAIN, SAUNDERS, PHILADELPHIA, PA, US, (200503), vol. 6, no. 3, ISSN 1526-5900, page S29, XP004796228 [Y] 1-71 * abstract * DOI: http://dx.doi.org/10.1016/j.jpain.2005.01.114 | Examination | - PANDYA K J ET AL, "Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial", THE LANCET, LANCET LIMITED. LONDON, GB, vol. 366, no. 9488, doi:10.1016/S0140-6736(05)67215-7, ISSN 0140-6736, (20050903), pages 818 - 824, (20050903), XP025277585 DOI: http://dx.doi.org/10.1016/S0140-6736(05)67215-7 | - GUTTUSO THOMAS JR ET AL, "Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial.", OBSTETRICS AND GYNECOLOGY FEB 2003 LNKD- PUBMED:12576259, (200302), vol. 101, no. 2, ISSN 0029-7844, pages 337 - 345, XP009156371 DOI: http://dx.doi.org/10.1016/S0029-7844(02)02712-6 |